Statements (34)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine
|
| gptkbp:administeredBy |
rabies immunoglobulin (in some cases)
|
| gptkbp:approvedBy |
gptkb:FDA
gptkb:EMA |
| gptkbp:boosterRecommended |
for high-risk individuals
|
| gptkbp:canBe |
animals
humans |
| gptkbp:category |
vaccine
|
| gptkbp:contains |
inactivated rabies virus
|
| gptkbp:developedBy |
gptkb:Louis_Pasteur
1885 |
| gptkbp:duration |
years
|
| https://www.w3.org/2000/01/rdf-schema#label |
rabies vaccines
|
| gptkbp:notRecommendedFor |
severe allergic reaction to previous dose
|
| gptkbp:regimen |
multiple doses
day 0, 3, 7, 14, 28 (post-exposure) day 0, 7, 21 or 28 (pre-exposure) |
| gptkbp:routeOfAdministration |
intramuscular
intradermal |
| gptkbp:sideEffect |
fever
headache allergic reaction pain at injection site |
| gptkbp:storage |
2-8°C
|
| gptkbp:type |
nerve tissue vaccine
cell culture vaccine egg-based vaccine |
| gptkbp:usedFor |
prevention of rabies
|
| gptkbp:usedIn |
post-exposure prophylaxis
pre-exposure prophylaxis |
| gptkbp:WHOStatus |
gptkb:World_Health_Organization's_List_of_Essential_Medicines
|
| gptkbp:bfsParent |
gptkb:J07BK01
gptkb:J07BM02 |
| gptkbp:bfsLayer |
7
|